GB202116263D0 - Anti-infective bicyclic peptide ligands - Google Patents

Anti-infective bicyclic peptide ligands

Info

Publication number
GB202116263D0
GB202116263D0 GBGB2116263.1A GB202116263A GB202116263D0 GB 202116263 D0 GB202116263 D0 GB 202116263D0 GB 202116263 A GB202116263 A GB 202116263A GB 202116263 D0 GB202116263 D0 GB 202116263D0
Authority
GB
United Kingdom
Prior art keywords
infective
peptide ligands
bicyclic peptide
bicyclic
ligands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2116263.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BicycleTx Ltd
Original Assignee
BicycleTx Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BicycleTx Ltd filed Critical BicycleTx Ltd
Priority to GBGB2116263.1A priority Critical patent/GB202116263D0/en
Publication of GB202116263D0 publication Critical patent/GB202116263D0/en
Priority to PCT/GB2022/052865 priority patent/WO2023084234A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB2116263.1A 2021-11-11 2021-11-11 Anti-infective bicyclic peptide ligands Ceased GB202116263D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2116263.1A GB202116263D0 (en) 2021-11-11 2021-11-11 Anti-infective bicyclic peptide ligands
PCT/GB2022/052865 WO2023084234A1 (en) 2021-11-11 2022-11-11 Anti-infective bicyclic peptide ligands

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2116263.1A GB202116263D0 (en) 2021-11-11 2021-11-11 Anti-infective bicyclic peptide ligands

Publications (1)

Publication Number Publication Date
GB202116263D0 true GB202116263D0 (en) 2021-12-29

Family

ID=79163542

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2116263.1A Ceased GB202116263D0 (en) 2021-11-11 2021-11-11 Anti-infective bicyclic peptide ligands

Country Status (2)

Country Link
GB (1) GB202116263D0 (en)
WO (1) WO2023084234A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6900033B2 (en) * 2001-06-04 2005-05-31 Human Genome Sciences, Inc. Methods and compositions for modulating ACE-2 activity
EP2653543A1 (en) 2008-02-05 2013-10-23 Bicycle Therapeutics Limited Methods and Compositions
WO2021216845A1 (en) * 2020-04-22 2021-10-28 Dana-Farber Cancer Institute, Inc. Antiviral structurally-stabilized ace2 helix 1 peptides and uses thereof
US20230183291A1 (en) * 2020-05-15 2023-06-15 Bicycle TX Limited Anti-infective bicyclic peptide ligands
CN117120459A (en) * 2021-01-08 2023-11-24 拜斯科技术开发有限公司 Antiinfective bicyclic peptide ligands

Also Published As

Publication number Publication date
WO2023084234A1 (en) 2023-05-19

Similar Documents

Publication Publication Date Title
IL290089A (en) Heterotandem bicyclic peptide complexes
IL304241A (en) Heterotandem bicyclic peptide complexes
IL304211A (en) Anti-infective bicyclic peptide ligands
GB201900526D0 (en) Bicyclic peptide ligands specific for caix
GB201820320D0 (en) Bicyclic peptide ligands specific for FAPalpha
IL304207A (en) Anti-infective bicyclic peptide ligands
IL304209A (en) Anti-infective bicyclic peptide ligands
GB202116263D0 (en) Anti-infective bicyclic peptide ligands
GB202301857D0 (en) Anti-infective bicyclic peptide ligands
GB202210376D0 (en) Anti-infective bicyclic peptide ligands
GB202209990D0 (en) Anti-infective bicyclic peptide ligands
GB201900525D0 (en) Bicyclic peptide ligands specific for caix
GB202118141D0 (en) Bicyclic peptide ligands specific for KLK7
GB202019992D0 (en) Bicyclic peptide ligands specific for KLK7
GB202017927D0 (en) Bicyclic peptide ligands specific for transferrin
GB202118147D0 (en) Bicyclic peptide ligands specific for MMP9
GB202118139D0 (en) Bicyclic peptide ligands specific for KLK5
GB202019997D0 (en) Bicyclic peptide ligands specific for MMP9
GB201918495D0 (en) Bicyclic peptide ligands specific for il-46
GB202118143D0 (en) Bicyclic peptide ligands specific for IL-9
GB202118144D0 (en) Bicyclic peptide ligands specific for cathepsin G
GB202112507D0 (en) Bicyclic peptide ligands specific for psma
GB202019993D0 (en) Bicyclic peptide ligands specific for IL-9
GB202019994D0 (en) Bicyclic peptide ligands specific for Cathepsin G
GB202013804D0 (en) Bicyclic peptide ligands specific for psma

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)